Skip to main content

Advertisement

SpringerLink
Log in

Successful treatment with bendamustine and rituximab for paraneoplastic pemphigus

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Anhalt GJ, Kim SC, Stanley JR, Korman NJ, Jabs DA, Kory M, Izumi H, Ratrie H 3rd, Mutasim D, Ariss-Abdo L, Larib RS (1990) Paraneoplastic pemphigus. An autoimmune mucocutaneous disease associated with neoplasia. N Engl J Med 323:1729–1735

    Article  CAS  PubMed  Google Scholar 

  2. Yong AA, Tey HL (2013) Paraneoplastic pemphigus. Australas J Dermatol 54:241–250

    Article  PubMed  Google Scholar 

  3. Nishibori Y, Hashimoto T, Ishiko A, Shimizu H, Korman NJ, Nishikawa T (1995) Paraneoplastic pemphigus: the first case report from Japan. Dermatology 191:39–42

    Article  CAS  PubMed  Google Scholar 

  4. Stark GL, Goff DK, Spickett GP, Wojnarowska F, Langtry JA (2003) Paraneoplastic pemphigus occurring after radiotherapy for relapsed non-Hodgkin’s lymphoma in a patient with common variable immunodeficiency. Hematol J 4:154–158

    Article  CAS  PubMed  Google Scholar 

  5. Plumb R, Doolittle GC (1996) Paraneoplastic pemphigus in a patient with non-Hodgkin’s lymphoma. Am J Hematol 52:58–59

    Article  CAS  PubMed  Google Scholar 

  6. Anan T, Shimizu F, Hatano Y, Okamoto O, Katagiri K, Fujiwara S (2011) Paraneoplastic pemphigus associated with corneal perforation and cutaneous alternariosis: a case report and review of cases treated with rituximab. J Dermatol 38:1084–1089

    Article  CAS  PubMed  Google Scholar 

  7. Rummel M, Kaiser U, Balser C, Stauch M, Brugger W, Welslau M, Niederle N, Losem C, Boeck HP, Weidmann E, von Gruenhagen U, Mueller L, Sandherr M, Hahn L, Vereshchagina J, Kauff F, Blau W, Hinke A, Barth J; Study Group Indolent Lymphomas. Bendamustine plus rituximab versus fludarabine plus rituximab for patients with relapsed indolent and mantle-cell lymphomas: a multicentre, randomised, open-label, non-inferiority phase 3 trial. Lancet Oncol. 2016;17:57–66.

  8. Rummel MJ, Niederle N, Maschmeyer G, Banat GA, von Grünhagen U, Losem C, Kofahl-Krause D, Heil G, Welslau M, Balser C, Kaiser U, Weidmann E, Dürk H, Ballo H, Stauch M, Roller F, Barth J, Hoelzer D, Hinke A, Brugger W; Study group indolent Lymphomas (StiL). Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial. Lancet 2013;381:1203–1210.

  9. Higo T, Miyagaki T, Nakamura F, Shinohara A, Asano H, Abe H, Senda N, Yoshizaki A, Fukayama M, Kurokawa M (2015) Paraneoplastic pemphigus occurring after bendamustine and rituximab therapy for relapsed follicular lymphoma. Ann Hematol 94:683–685

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Hematology, Department of Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan

    Taku Kikuchi, Takehiko Mori, Takayuki Shimizu, Yuya Koda, Ryohei Abe & Shinichiro Okamoto

  2. Department of Dermatology, Keio University School of Medicine, Tokyo, Japan

    Yuichi Kurihara, Takeru Funakoshi, Jun Yamagami & Masayuki Amagai

  3. Department of Dentistry and Oral Surgery, Keio University School of Medicine, Tokyo, Japan

    Hidekazu Sato & Kazuyuki Tsunoda

Authors
  1. Taku Kikuchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Takehiko Mori
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Takayuki Shimizu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yuya Koda
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ryohei Abe
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yuichi Kurihara
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Takeru Funakoshi
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Jun Yamagami
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Hidekazu Sato
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Kazuyuki Tsunoda
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Masayuki Amagai
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Shinichiro Okamoto
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Taku Kikuchi.

Ethics declarations

Conflict of interest

SO received research funding and honoraria from Eisai Co. Ltd. and Chugai Pharmaceutical Co. Ltd. TM received honoraria from Eisai Co. Ltd. and Chugai Pharmaceutical Co. Ltd. TF received research funding and honoraria from Eisai Co. Ltd. and Chugai Pharmaceutical Co. Ltd.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kikuchi, T., Mori, T., Shimizu, T. et al. Successful treatment with bendamustine and rituximab for paraneoplastic pemphigus. Ann Hematol 96, 1221–1222 (2017). https://doi.org/10.1007/s00277-017-3008-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-017-3008-8

Keywords

Search

Navigation